Daniel Kwon

2 weeks ago | onlinelibrary.wiley.com | Tyler Gallagher |Matthew Lin |Ian Kim |Daniel Kwon

Conflicts of Interest The authors declare no conflicts of interest. Supporting Information Filename Description lary32340-sup-0001-Tables.docxWord 2007 document , 47.2 KB Table S1. ICD-10, CPT, SNOMED, and TriNetX codes. Table S2. Hazard ratio for mortality after HNC diagnosis with or without anxiety and/or depressive disorder diagnosis*. Table S3. Hazard ratio for mortality after HNC diagnosis with or without treatment for anxiety and/or depressive disorder diagnosis*. Table S4.

Nov 26, 2024 | urologytimes.com | Daniel Kwon

In this video, Daniel Kwon, MD, discusses the impact of the JNCI Cancer Spectrum paper, “Germline testing for veterans with advanced prostate cancer: concerns about service-connected benefits." Kwon is an assistant professor of medicine at the University of California, San Francisco. Transcription:Your research led to changes in the Veterans Benefits Administration Compensation and Pension Manual.

Nov 21, 2024 | urologytimes.com | Daniel Kwon

In this video, Daniel Kwon, MD, discusses how clinicians can use information from the JNCI Cancer Spectrum paper, “Germline testing for veterans with advanced prostate cancer: concerns about service-connected benefits” to counsel patients. Kwon is an assistant professor of medicine at the University of California, San Francisco.

Nov 18, 2024 | urologytimes.com | Daniel Kwon

In this video, Daniel Kwon, MD, discusses implications from the JNCI Cancer Spectrum paper, “Germline testing for veterans with advanced prostate cancer: concerns about service-connected benefits.” Kwon is an assistant professor of medicine at the University of California, San Francisco. Transcription:The finding that veterans with service-connected disability benefits were hesitant to undergo germline testing due to fear of benefit loss is significant.

Nov 11, 2024 | urologytimes.com | Daniel Kwon

OpinionVideoNovember 11, 2024Author(s):"We were trying to understand how veterans were making decisions about germline testing for their prostate cancer," says Daniel Kwon, MD. In this video, Daniel Kwon, MD, discusses the background and notable findings from the JNCI Cancer Spectrum paper, “Germline testing for veterans with advanced prostate cancer: concerns about service-connected benefits.” Kwon is an assistant professor of medicine at the University of California, San Francisco.